Enfusion

Enfusion Current Liabilities

Delisted

The Current Liabilities of Enfusion (ENFN) as of Nov 7, 2026 is 52.41 M USD. In the previous year, Current Liabilities was 36.01 M USD — a change of 45.55% (higher).

Current Liabilities

52.41 MUSD

YoY

45.55%

Last updated:

Current Liabilities of Enfusion is 2024 52.41 M USD. Current Liabilities of Enfusion was 2023 36.01 M USD. It decreases by 45.55% higher compared to the previous year.

The Enfusion Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
15.16 M USD
Jan 1, 2020
20.11 M USD
Jan 1, 2021
12.49 M USD
Jan 1, 2022
32.80 M USD
Jan 1, 2023
36.01 M USD
Jan 1, 2024
52.41 M USD
The Enfusion Current Liabilities history
YEARCurrent LiabilitiesYoY
52.41 MUSD+45.55%
36.01 MUSD+9.80%
32.80 MUSD+162.57%
12.49 MUSD-37.88%
20.11 MUSD+32.66%
15.16 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Current Liabilities of Enfusion is 52.41 M USD in 2024.

Current Liabilities of Enfusion changed from 36.01 M USD to 52.41 M USD, representing a 45.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Enfusion since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Enfusion

All Key Metrics — Enfusion